Why the study?
There is widespread interest in expanding the uptake of home dialysis in North America, but randomized comparisons are limited and nonrandomized studies yield conflicting results prone to bias.
Does home dialysis provide equivalent clinical outcomes and quality of life at a lower cost compared to in-center hemodialysis in patients requiring kidney replacement therapy?
Does home dialysis provide equivalent clinical outcomes and quality of life at a lower cost compared to in-center hemodialysis in patients requiring kidney replacement therapy?
Home dialysis offers equivalent clinical outcomes and quality of life at a lower cost compared to in-center hemodialysis, supporting its expanded uptake.
Home dialysis may be cost-effective; leaves open need for feasible RCTs to guide uptake.
There is widespread interest in expanding the uptake of home dialysis in North America. Although kidney transplantation should be the preferred option in eligible patients, home hemodialysis (HD) and peritoneal dialysis (PD) offer cost-effective options for KRT. In this review, the motivation for promoting home dialysis is presented, and the literature supporting it is critically reviewed. Randomized comparisons of home HD and PD with in-center HD have been challenging to conduct and provide only limited information. Nonrandomized studies are heterogeneous in their design and have often yielded conflicting results. They are prone to bias, and this must be carefully considered when evaluating this literature. Home modalities seem to have equivalent clinical outcomes and quality of life when compared with in-center HD. However, the cost of providing home therapies, particularly PD, is lower than conventional, in-center HD. Measures of home dialysis utilization, the philosophy behind their measurement, and important factors to consider when interpreting them are discussed. The importance of understanding measures of home dialysis utilization in the context of rates of kidney failure, the proportion of individuals who opt for conservative care, and rates of kidney transplantation is highlighted, and a framework for proposing targets is presented, using PD as an example.
No takes yet. Share an insight, caveat, or question.
Quinn et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: